Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: Cyclophosphamide Drug Interaction Study In Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating drug interactions with cyclophosphamide in cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cytoxan (cyclophosphamide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nausea and Vomiting, Chemotherapy-Induced | Phase 1 | Status: TERMINATED